NYSE · SEC CIK 0001100682
This is the supported SEC-traceable subset, not total insider ownership or personal wealth. Values reflect the current disclosed positions Grizzly Bulls can resolve and value. Latest source filing: Aug 27, 2026 · values through Sep 25, 2026.
Filter the reporting-owner snapshot by holder, role, or security. Position values are shown only where the current reviewed data supports them.
| Holder | Role | Position | Current value | Latest filing |
|---|---|---|---|---|
| Birgit GirshickResearch disclosed relationships | Chief Executive Officer · Director | 35,485 sharesCommon stock, $0.01 par value | $10.39M | Aug 20, 2026 |
| James C. FosterResearch disclosed relationships | Director | 31,596 sharesCommon stock, $0.01 par value | $9.25M | Aug 27, 2026 |
| Michael Gunnar KnellResearch disclosed relationships | SVP, Finance and CAO | 11,852 sharesCommon stock, $0.01 par value | $3.47M | Aug 10, 2026 |
| Shannon M. ParisottoResearch disclosed relationships | CEVP, Disc & Safety Assessment | 4,807 sharesCommon stock, $0.01 par value | $1.41M | Aug 20, 2026 |
These relationships are joined only when the same single SEC reporting-owner CIK appears unambiguously across the publication-authorized company ownership universe. Name similarity is never used to create a relationship.
SEC reporting-owner CIK 0001732091 · 1 published company relationship
| Company | SEC relationship | Covered position | Current covered value | Latest filing | Research |
|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE · Current company | Chief Executive Officer · Director | 35,485 sharesCommon stock, $0.01 par value | $10.39M | Aug 20, 2026 |
SEC reporting-owner CIK 0001141722 · 1 published company relationship
| Company | SEC relationship | Covered position | Current covered value | Latest filing | Research |
|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE · Current company | Director | 31,596 sharesCommon stock, $0.01 par value | $9.25M | Aug 27, 2026 |
SEC reporting-owner CIK 0001543779 · 1 published company relationship
| Company | SEC relationship | Covered position | Current covered value | Latest filing | Research |
|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE · Current company | SVP, Finance and CAO | 11,852 sharesCommon stock, $0.01 par value | $3.47M | Aug 10, 2026 |
SEC reporting-owner CIK 0001952784 · 1 published company relationship
| Company | SEC relationship | Covered position | Current covered value | Latest filing | Research |
|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE · Current company | CEVP, Disc & Safety Assessment | 4,807 sharesCommon stock, $0.01 par value | $1.41M | Aug 20, 2026 |
This graph is bounded to the company ownership relationships currently published by Grizzly Bulls. It is not a complete employment, board, ownership, portfolio, or wealth history, and a missing relationship does not establish that none exists.
Each row preserves the reviewed SEC transaction evidence, including the effective-date basis, amendment state, reported post-transaction position when present, and a separately published current covered owner/security position when one can be matched uniquely. Reported price is shown when present. The lab does not calculate gross proceeds, reconstruct balances between filings, or treat historical transactions as current wealth.
| Effective date | Holder | Action | Security | Units | Reported price | Reported position after transaction | Current covered position | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026Transaction date | James C. FosterResearch disclosed relationships | SaleSEC code S | Common stock, $0.01 par value | 33,561 shares | $300 | 31,596 shares | 31,596 sharesOwner coverage latest filing Aug 27, 2026 | 4Filed Aug 27, 2026 |
| Aug 25, 2026Transaction date | James C. FosterResearch disclosed relationships | AcquisitionSEC code M | Common stock, $0.01 par value | 12,429 shares | $208.44 | 65,157 shares | 31,596 sharesOwner coverage latest filing Aug 27, 2026 | 4Filed Aug 27, 2026 |
| Aug 25, 2026Transaction date | James C. FosterResearch disclosed relationships | AcquisitionSEC code M | Common stock, $0.01 par value | 21,132 shares | $194.12 | 52,728 shares | 31,596 sharesOwner coverage latest filing Aug 27, 2026 | 4Filed Aug 27, 2026 |
| Aug 19, 2026Transaction date | Birgit GirshickResearch disclosed relationships | DispositionSEC code G | Common stock, $0.01 par value | 528 shares | $0 | 35,485 shares | 35,485 sharesOwner coverage latest filing Aug 20, 2026 | 4Filed Aug 20, 2026 |
| Aug 19, 2026Transaction date | Shannon M. ParisottoResearch disclosed relationships | SaleSEC code S | Common stock, $0.01 par value | 2,039 shares | $294.12 | 4,807 shares | 4,807 sharesOwner coverage latest filing Aug 20, 2026 | 4Filed Aug 20, 2026 |
| Aug 19, 2026Transaction date | Shannon M. ParisottoResearch disclosed relationships | AcquisitionSEC code M | Common stock, $0.01 par value | 2,039 shares | $194.12 | 6,846 shares | 4,807 sharesOwner coverage latest filing Aug 20, 2026 | 4Filed Aug 20, 2026 |
| Aug 11, 2026Transaction date | Birgit GirshickResearch disclosed relationships | SaleSEC code S | Common stock, $0.01 par value | 6,500 shares | $279.9 | 36,013 shares | 35,485 sharesOwner coverage latest filing Aug 20, 2026 | 4Filed Aug 13, 2026 |
| Aug 11, 2026Transaction date | Birgit GirshickResearch disclosed relationships | AcquisitionSEC code M | Common stock, $0.01 par value | 6,500 shares | $179.66 | 42,513 shares | 35,485 sharesOwner coverage latest filing Aug 20, 2026 | 4Filed Aug 13, 2026 |
| Aug 11, 2026Transaction date | Shannon M. ParisottoResearch disclosed relationships | SaleSEC code S | Common stock, $0.01 par value | 3,714 shares | $279.66 | 4,807 shares | 4,807 sharesOwner coverage latest filing Aug 20, 2026 | 4Filed Aug 13, 2026 |
| Aug 11, 2026Transaction date | Shannon M. ParisottoResearch disclosed relationships | AcquisitionSEC code M | Common stock, $0.01 par value | 3,714 shares | $179.66 | 8,521 shares | 4,807 sharesOwner coverage latest filing Aug 20, 2026 | 4Filed Aug 13, 2026 |
| Aug 10, 2026Transaction date | James C. FosterResearch disclosed relationships | SaleSEC code S | Common stock, $0.01 par value | 28,733 shares | $275 | 31,596 shares | 31,596 sharesOwner coverage latest filing Aug 27, 2026 | 4Filed Aug 11, 2026 |
| Aug 10, 2026Transaction date | James C. FosterResearch disclosed relationships | AcquisitionSEC code M | Common stock, $0.01 par value | 28,733 shares | $179.66 | 60,329 shares | 31,596 sharesOwner coverage latest filing Aug 27, 2026 | 4Filed Aug 11, 2026 |
A reported post-transaction position is the balance stated in that historical transaction filing. A current covered position is a separate latest owner/security observation and may reflect later filings or activity. They are shown side by side as evidence points, not as a reconstructed continuous ledger.
Published 12 of 28 source candidates under the current reviewed security-resolution rules.
| Security | Instrument family | Covered positions | Covered value |
|---|---|---|---|
| Common stock, $0.01 par value | ordinary-share | 4 | $24.52M |
Current holdings: direct positions that the reviewed ownership data can trace to an exact reporting owner, legal security, and current-basis quantity.
Current value: the existing published company-position valuation. This lab does not recalculate security values or infer missing positions.
Transaction evidence: historical flow observations with filing provenance. Reported post-transaction balances and current covered positions are separate evidence points; the lab does not interpolate ownership between them.
Reporting-owner graph: exact reporting-owner CIK relationships across the published company universe. It does not merge people by name or create a complete personal history.
Not included here: a claim of total insider ownership, total personal wealth, institutional 13F ownership, a transaction-value estimate, an insider sentiment score, or an investment recommendation.
This sequence orders only the ownership evidence already published by Grizzly Bulls for the exact reporting-owner relationships above. Transaction rows are ordered by filing date while preserving the separate economic effective date and its basis. Current covered snapshots remain separate latest observations.
The chronology does not interpolate ownership between entries, infer missing activity, pair an amended filing with an assumed parent, infer amendment supersession, or treat a current covered snapshot as proof of continuous ownership.
| Evidence date | Company | Observation | Security / position | Source |
|---|---|---|---|---|
| Aug 20, 2026Latest represented filing date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | Current covered snapshotChief Executive Officer · DirectorValuation observation Sep 25, 2026 | Common stock, $0.01 par value: 35,485 sharesCurrent covered company value: $10.39M | Published current ownership snapshotForms represented: 4Owner filingsIssuer filings |
| Aug 20, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | DispositionSEC code GEffective Aug 19, 2026 · transaction dateReported units 528 shares · reported price 0 | Common stock, $0.01 par valueReported position after transaction: 35,485 shares | 4 filing0001100682-26-000138 |
| Aug 13, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | AcquisitionSEC code MEffective Aug 11, 2026 · transaction dateReported units 6,500 shares · reported price 179.66 | Common stock, $0.01 par valueReported position after transaction: 42,513 shares | 4 filing0001100682-26-000132 |
| Aug 13, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | SaleSEC code SEffective Aug 11, 2026 · transaction dateReported units 6,500 shares · reported price 279.9 | Common stock, $0.01 par valueReported position after transaction: 36,013 shares | 4 filing0001100682-26-000132 |
Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 3 published transaction rows for this exact reporting-owner CIK appear in the chronology. 1 relationship company is at the current public transaction-row limit; that does not prove additional rows exist.
| Evidence date | Company | Observation | Security / position | Source |
|---|---|---|---|---|
| Aug 27, 2026Latest represented filing date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | Current covered snapshotDirectorValuation observation Sep 25, 2026 | Common stock, $0.01 par value: 31,596 sharesCurrent covered company value: $9.25M | Published current ownership snapshotForms represented: 4Owner filingsIssuer filings |
| Aug 27, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | AcquisitionSEC code MEffective Aug 25, 2026 · transaction dateReported units 21,132 shares · reported price 194.12 | Common stock, $0.01 par valueReported position after transaction: 52,728 shares | 4 filing0001100682-26-000140 |
| Aug 27, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | AcquisitionSEC code MEffective Aug 25, 2026 · transaction dateReported units 12,429 shares · reported price 208.44 | Common stock, $0.01 par valueReported position after transaction: 65,157 shares | 4 filing0001100682-26-000140 |
| Aug 27, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | SaleSEC code SEffective Aug 25, 2026 · transaction dateReported units 33,561 shares · reported price 300 | Common stock, $0.01 par valueReported position after transaction: 31,596 shares | 4 filing0001100682-26-000140 |
| Aug 11, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | AcquisitionSEC code MEffective Aug 10, 2026 · transaction dateReported units 28,733 shares · reported price 179.66 | Common stock, $0.01 par valueReported position after transaction: 60,329 shares | 4 filing0001100682-26-000126 |
| Aug 11, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | SaleSEC code SEffective Aug 10, 2026 · transaction dateReported units 28,733 shares · reported price 275 | Common stock, $0.01 par valueReported position after transaction: 31,596 shares | 4 filing0001100682-26-000126 |
Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 5 published transaction rows for this exact reporting-owner CIK appear in the chronology. 1 relationship company is at the current public transaction-row limit; that does not prove additional rows exist.
| Evidence date | Company | Observation | Security / position | Source |
|---|---|---|---|---|
| Aug 10, 2026Latest represented filing date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | Current covered snapshotSVP, Finance and CAOValuation observation Sep 25, 2026 | Common stock, $0.01 par value: 11,852 sharesCurrent covered company value: $3.47M | Published current ownership snapshotForms represented: 4Owner filingsIssuer filings |
Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 0 published transaction rows for this exact reporting-owner CIK appear in the chronology. 1 relationship company is at the current public transaction-row limit; that does not prove additional rows exist.
| Evidence date | Company | Observation | Security / position | Source |
|---|---|---|---|---|
| Aug 20, 2026Latest represented filing date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | Current covered snapshotCEVP, Disc & Safety AssessmentValuation observation Sep 25, 2026 | Common stock, $0.01 par value: 4,807 sharesCurrent covered company value: $1.41M | Published current ownership snapshotForms represented: 4Owner filingsIssuer filings |
| Aug 20, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | AcquisitionSEC code MEffective Aug 19, 2026 · transaction dateReported units 2,039 shares · reported price 194.12 | Common stock, $0.01 par valueReported position after transaction: 6,846 shares | 4 filing0001100682-26-000136 |
| Aug 20, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | SaleSEC code SEffective Aug 19, 2026 · transaction dateReported units 2,039 shares · reported price 294.12 | Common stock, $0.01 par valueReported position after transaction: 4,807 shares | 4 filing0001100682-26-000136 |
| Aug 13, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | AcquisitionSEC code MEffective Aug 11, 2026 · transaction dateReported units 3,714 shares · reported price 179.66 | Common stock, $0.01 par valueReported position after transaction: 8,521 shares | 4 filing0001100682-26-000130 |
| Aug 13, 2026Filed date | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE | SaleSEC code SEffective Aug 11, 2026 · transaction dateReported units 3,714 shares · reported price 279.66 | Common stock, $0.01 par valueReported position after transaction: 4,807 shares | 4 filing0001100682-26-000130 |
Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 4 published transaction rows for this exact reporting-owner CIK appear in the chronology. 1 relationship company is at the current public transaction-row limit; that does not prove additional rows exist.
These handoffs preserve the exact company identities already represented in the reporting-owner graph. My Stocks keeps a listed company in your existing research lists. Research Inbox is a separate company-change update workflow.
Saving a company to My Stocks never enables updates, and opening Research Inbox never subscribes you automatically. Each update remains an explicit company-level opt-in under the existing Research Inbox consent flow.
| Company | Reporting-owner context | Published evidence | Continue research |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)NYSE · Current company | Birgit GirshickSEC CIK 00017320914 chronology observationsJames C. FosterSEC CIK 00011417226 chronology observationsMichael Gunnar KnellSEC CIK 00015437791 chronology observationShannon M. ParisottoSEC CIK 00019527845 chronology observations | 16Published chronology observationsLatest represented evidence Aug 27, 2026 |
These are company-level continuation paths, not reporting-owner subscriptions. Saving or watching one company does not automatically save or watch the other companies connected to the same reporting owner, and it does not create an owner-level alert.
